SS

Sukriti Sharma

Active Director Director DIN 09682528
DIN 09682528 First appointment Jul 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value •••• Premium profile

About Sukriti Sharma

Data last updated:

Sukriti Sharma is a Director at Anphar Laboratories Private Limited (since 2022). The company operates in Pharma. Anphar Laboratories Private Limited reported revenue of ₹20.75 Cr (FY 2025).

DIN 09682528
Primary Designation Director
Industry Pharma
First Appointment 22 Jul 2022
Oldest Company Age 39 yrs
Largest company Anphar Laboratories Private Limited · ₹20.75 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Anphar Laboratories Private Limited U33112JK1987PTC000930
Director22 Jul 20221987₹20.75 Cr (FY 2025)Active

Board colleagues of Sukriti Sharma

Directorship timeline

Open interactive timeline →
Anphar Laboratories Private Limited
Premium access

Shareholding and investment profile for Sukriti Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sukriti Sharma

Sukriti Sharma currently holds 1 directorship: Anphar Laboratories Private Limited (Director, since 22 Jul 2022, revenue ₹20.75 Cr (FY 2025)).

Sukriti Sharma was first appointed on 22 Jul 2022 as Director at Anphar Laboratories Private Limited.

The current boards of Sukriti Sharma's companies include Anil Gupta (Anphar Laboratories Private Limited), Ankit Gupta (Anphar Laboratories Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available